The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AKY-2519, a novel B7-H3-targeted radioconjugate, and its biodistribution profile in patients with mCRPC.
 
Michael Sathekge
Leadership - Adcock Ingram; Africa Health Research Institute
Honoraria - Elsevier
Consulting or Advisory Role - NTP Radioistopes
Speakers' Bureau - Aktis; GE Healthcare
Research Funding - Alpha-9 Theranostics (Inst); AstraZeneca (Inst); Lilly (Inst); Molecular Partners (Inst); Novartis (Inst); Tellix - Rhino (Inst)
Travel, Accommodations, Expenses - Aktis (Inst); GE Healthcare; United
 
Julius Mugisha
No Relationships to Disclose
 
Joseph Kabunda
Employment - NuMeRI
Research Funding - NuMURI
Travel, Accommodations, Expenses - NuMeRI
 
Keamogetswe Ramonaheng
Consulting or Advisory Role - Advancell
 
Milani Qebetu
No Relationships to Disclose
 
Kaluzi Banda
No Relationships to Disclose
 
Pryaska Goorhoo
No Relationships to Disclose
 
Sandile Sibiya
No Relationships to Disclose
 
Sipho Mdanda
No Relationships to Disclose
 
Honest Ndlovu
No Relationships to Disclose
 
Kgomotso Mokoala
No Relationships to Disclose
 
Cindy Davis
No Relationships to Disclose
 
Liani Smith
No Relationships to Disclose
 
Yonwaba Mzizi
No Relationships to Disclose
 
Haofei Wang
Employment - Aktis Oncology; Biogen (I); GlaxoSmithKline (I); Tango Therapeutics
Stock and Other Ownership Interests - Aktis Oncology; Biogen (I); GlaxoSmithKline (I)
 
Janet Horton
Employment - Aktis Oncology
Stock and Other Ownership Interests - Aktis Oncology
 
Akos Czibere
Employment - Aktis Oncology
Stock and Other Ownership Interests - Aktis Oncology
 
Ken Herrmann
Leadership - Aktis Oncology; Pentixapharm
Stock and Other Ownership Interests - AdvanCell; Aktis Oncology; Convergent Therapeutics; NVision; Radiopharm Theranostics; SOFIE; Yellowbird Diagnostics
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; AstraZeneca; Bain Capital; Bayer; Boston Scientific; BTG; Debiopharm Group; Fusion Pharmaceuticals; GE Healthcare; Immedica; IPSEN; ITG (Inst); Janssen Oncology; Molecular Partners; Novartis; Radiopharm Theranostics; ROTOP Pharmaka (Inst); Siemens Healthineers; Telix Pharmaceuticals